MDXG Q2 2018 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95M+24.9% YoY

Gross Profit

$86M90.3% margin

Operating Income

$2M1.8% margin

Net Income

$2M1.9% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+13.4%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$18M

Stock-Based Comp.

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95M	$76M	+24.9%
Gross Profit	$86M	$68M	+27.1%
Operating Income	$2M	$7M	-76.8%
Net Income	$2M	$8M	-77.6%